Cargando…
Metabolomics-based profiles predictive of low bone mass in menopausal women
Osteoporosis is a skeletal disorder characterized by compromised bone strength and increased risk of fracture. Low bone mass and/or pre-existing bone fragility fractures serve as diagnostic criteria in deciding when to start medication for osteoporosis. Although osteoporosis is a metabolic disorder,...
Autores principales: | Miyamoto, Takeshi, Hirayama, Akiyoshi, Sato, Yuiko, Koboyashi, Tami, Katsuyama, Eri, Kanagawa, Hiroya, Fujie, Atsuhiro, Morita, Mayu, Watanabe, Ryuichi, Tando, Toshimi, Miyamoto, Kana, Tsuji, Takashi, Funayama, Atsushi, Soga, Tomoyoshi, Tomita, Masaru, Nakamura, Masaya, Matsumoto, Morio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019687/ https://www.ncbi.nlm.nih.gov/pubmed/29955645 http://dx.doi.org/10.1016/j.bonr.2018.06.004 |
Ejemplares similares
-
The Vitamin D Analogue ED71 but Not 1,25(OH)(2)D(3) Targets HIF1α Protein in Osteoclasts
por: Sato, Yuiko, et al.
Publicado: (2014) -
A Metabolomic Profile Predictive of New Osteoporosis or Sarcopenia Development
por: Miyamoto, Kana, et al.
Publicado: (2021) -
Hao1 Is Not a Pathogenic Factor for Ectopic Ossifications but Functions to Regulate the TCA Cycle In Vivo
por: Kimura, Atsushi, et al.
Publicado: (2022) -
Enpp1 is an anti-aging factor that regulates Klotho under phosphate overload conditions
por: Watanabe, Ryuichi, et al.
Publicado: (2017) -
Selective Estrogen Receptor Modulators Suppress Hif1α Protein Accumulation in Mouse Osteoclasts
por: Morita, Mayu, et al.
Publicado: (2016)